Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1

This study is ongoing, but not recruiting participants.

Study NCT00678886 Information provided by GlaxoSmithKline

First Received: May 13, 2008 Last Updated: January 26, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2012
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)